Crossmark Global Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.92M | Buy |
53,158
+40,229
| +311% | +$2.21M | 0.05% | 335 |
|
|
2025
Q1 | $914K | Buy |
12,929
+23
| +0.2% | +$1.63K | 0.02% | 639 |
|
|
2024
Q4 | $848K | Sell |
12,906
-416
| -3% | -$27.3K | 0.02% | 627 |
|
|
2024
Q3 | $937K | Buy |
13,322
+2,277
| +21% | +$160K | 0.02% | 631 |
|
|
2024
Q2 | $909K | Buy |
+11,045
| New | +$909K | 0.02% | 614 |
|
|
2023
Q2 | – | Sell |
-2,128
| Closed | -$207K | – | 1302 |
|
|
2023
Q1 | $207K | Buy |
2,128
+105
| +5% | +$10.2K | ﹤0.01% | 1214 |
|
|
2022
Q4 | $209K | Buy |
+2,023
| New | +$209K | 0.01% | 1183 |
|
|
2018
Q4 | – | Sell |
-5,218
| Closed | -$506K | – | 1408 |
|
|
2018
Q3 | $506K | Sell |
5,218
-80
| -2% | -$7.76K | 0.01% | 940 |
|
|
2018
Q2 | $499K | Sell |
5,298
-550
| -9% | -$51.8K | 0.01% | 948 |
|
|
2018
Q1 | $474K | Sell |
5,848
-1,848
| -24% | -$150K | 0.01% | 948 |
|
|
2017
Q4 | $686K | Buy |
7,696
+228
| +3% | +$20.3K | 0.02% | 798 |
|
|
2017
Q3 | $695K | Buy |
+7,468
| New | +$695K | 0.02% | 768 |
|
|
2016
Q3 | $695K | Buy |
+7,468
| New | +$695K | 0.02% | 768 |
|